Researchers at the CiRA Foundation in Kyoto, Japan, have published a detailed study [1] showing how carefully defined culture ...
A group of researchers in Japan says it has confirmed a certain level of efficacy in using iPS cell-derived immune cells for ...
Center for iPS Cell Research Application (CiRA) of Kyoto University and Takeda Pharmaceutical Company Limited (Takeda) announced today that they will work together to develop clinical applications of ...
Hosted on MSN
Japan's iPS Cell Breakthroughs Are Reshaping Regenerative Medicine and Parkinson's Treatment
“It is a significant achievement that we have been able to confirm improvement in patients’ symptoms,” Director of Kyoto University’s Center for iPS Cell Research and Application (CiRA) Jun Takahashi ...
A team developed a human iPS cell-derived kidney organoid-based proximal tubule-on-chip -- OPTECs-on-Chip -- that mimics in vivo renal physiology more closely than ever before. This model exhibits ...
Three lines of GMP iPS Cells derived from type O female blood are now offered as off-the-shelf product It is well known that HLA homozygous iPSCs are often selected to reduce adverse immune response ...
iPS cell technology enables the creation of age-reversed stem cells that reflect a younger version of the individual's biology. I Peace is now expanding the use of this breakthrough not only for ...
TOKYO (Reuters) - Japanese scientists said on Monday they will start clinical trials next month on a treatment for Parkinson's disease, transplanting "reprogrammed" stem cells into brains, seeking a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results